Advanced drug development and manufacturing
Patent
·
OSTI ID:1771770
X-ray fluorescence (XRF) spectrometry has been used for detecting binding events and measuring binding selectivities between chemicals and receptors. XRF may also be used for estimating the therapeutic index of a chemical. For estimating the binding selectivities of a chemical versus chemical analogs, for measuring post translational modification of proteins, and for drug manufacturing.
- Research Organization:
- Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC52-06NA25396
- Assignee:
- ICAGEN, LLC (San Diego, CA)
- Patent Number(s):
- 10,877,035
- Application Number:
- 14/693,094
- OSTI ID:
- 1771770
- Resource Relation:
- Patent File Date: 04/22/2015
- Country of Publication:
- United States
- Language:
- English
Similar Records
Drug development and manufacturing
Rapid and Simultaneous Characterization of Drug Conjugation in Heavy and Light Chains of a Monoclonal Antibody Revealed by High-Resolution Ion Mobility Separations in SLIM
The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity
Patent
·
Tue Oct 13 00:00:00 EDT 2015
·
OSTI ID:1771770
Rapid and Simultaneous Characterization of Drug Conjugation in Heavy and Light Chains of a Monoclonal Antibody Revealed by High-Resolution Ion Mobility Separations in SLIM
Journal Article
·
Fri Mar 06 00:00:00 EST 2020
· Analytical Chemistry
·
OSTI ID:1771770
+6 more
The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity
Journal Article
·
Sat May 15 00:00:00 EDT 2010
· Toxicology and Applied Pharmacology
·
OSTI ID:1771770